Pharmaceutical and preclinical evaluation of Advax adjuvant as a dose-sparing strategy for ant venom immunotherapy

A major challenge in broader clinical application of Jack Jumper ant venom immunotherapy (JJA VIT) is the scarcity of ant venom which needs to be manually harvested from wild ants. Adjuvants are commonly used for antigen sparing in other vaccines, and thereby could potentially have major benefits to...

Descripción completa

Detalles Bibliográficos
Autores principales: Wanandy, Troy, Honda-Okubo, Yoshikazu, Davies, Noel W., Rose, Hayley E., Heddle, Robert J., Brown, Simon G.A., Woodman, Richard J., Petrovsky, Nikolai, Wiese, Michael D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127811/
https://www.ncbi.nlm.nih.gov/pubmed/31009889
http://dx.doi.org/10.1016/j.jpba.2019.04.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127811/
https://www.ncbi.nlm.nih.gov/pubmed/31009889
http://dx.doi.org/10.1016/j.jpba.2019.04.017

Ejemplares similares